US Patent 11224659 Solid solution compositions and use in severe pain
Patent 11224659 was granted and assigned to infirst Healthcare on January, 2022 by the United States Patent and Trademark Office.
All edits
The present specification discloses solid solution pharmaceutical compositions comprising therapeutic compound comprising a phytocannabinoid, an endocannabinoid, a synthetic cannabinoid, or a combination thereof, one or more pharmaceutically-acceptable hard fats in an amount of at least 30% by weight of the pharmaceutical composition, and one or more pharmaceutically-acceptable liquid lipids in an amount of less than 45% by weight of the pharmaceutical composition, methods of preparing such pharmaceutical compositions, and methods and uses of treating a chronic inflammation and/or an inflammatory disease in an individual using such pharmaceutical compositions.
US Patent 11224659 Solid solution compositions and use in severe pain
Find more entities like US Patent 11224659 Solid solution compositions and use in severe pain
